Abstract
Ten euthyroid and 9 hypothyroid volunteers were orally administered 2 mg L-thyroxine (T4) to study the interaction between substitutive and suppressive effects of a single high T4 dose. After a significant rise in the serum T4 concentration for 5 days in euthyroid and for 11 days in hypothyroid patients an inhibition of basal and of TRH stimulated TSH release was observed. Maximal inhibition of the TSH response in hypothyroid patients occurred 1 to 7 days after the individual T4 peak. This interval was significantly correlated to the extent of the respective T4 rise. In euthyroid subjects TSH response was significantly inhibited for 8, in hypothyroid patients for 22 days. In all but 3 of the euthyroid patients there was a significant inhibition of the thyroidal 132I uptake on day 8. Normalization of thyroidal 132I uptake and of pituitary TSH secretion generally coincided.
Similar content being viewed by others
References
Wallack W.S., Adelberg H.M, Nicoloff J.T. A thyroid suppression test using a single dose of L-thyroxine. N. Engl. J. Med. 283: 401, 1970.
Bernstein R.S., Robbins J. Intermittent therapy with L-thyroxine. N. Engl. J. Med. 281: 26,1969.
Sekadde C.B., Slaunwhite jr. W.R., Aceto jr. T., Murray K. Administration of thyroxine once a week. J. Clin. Endocrinol. Metab. 39: 759, 1974.
Holvey D.N., Goodner C.J., Nicoloff J.T., Dowling J.T. Treatment of myxedema coma with intravenous thyroxine. Arch. Intern. Med. 113: 139, 1964.
Ridgeway E.C., McCammon J.A., Benotti J., Maloof F. Metabolic responses in myxedema to large doses of intravenous L-thyroxine. Ann. Intern. Med. 77: 549, 1972.
Alexander W.D., McG Harden R., Shimmins J. Thyroidal suppressibility by triiodothyronine as a guide to duration of treatment of thyrotoxicosis with antithyroid drugs. Lancet 2: 1041, 1966.
Vice P.A., Clarck F., Schardt W., Evered D. Studies on the control of thyrotropin secretion in normal man. Clin. Endocrinol. (Oxf.) 5: 515, 1976.
Wenzel K.W., Meinhold H., Schleusener H. Different effects of oral doses of triiodothyronine of thyroxine on the inhibition of thyrotropin releasing hormone (TSH) mediated thyrotropin (TSH) response in man. Acta Endocrinol. (Kbh.) 80: 42, 1975.
Ljundgren J.G., Persson B. Subcutaneous administration of sodium L-thyroxine to patients with hypothyroidism. Acta Med. Scand. 197: 471, 1975.
Wenzel K.W. Einmal wöchentliche intravenöse L-Thyroxin-Substitution bei Hypothyreose. Schweiz. Med. Wochenschn. 108: 416, 1978.
Bowers C.Y., Lee K.L., Schally A.V. A study on the interaction of the thyrotropin-releasing factor and L-triiodothyronine: Effects of puromycin and cyclohexemide. Endocrinology 82: 75, 1968.
Vale W., Burgus R., Guillemin R. On the mechanism of action of TRF: Effects of cyclohexemide and actinomycin on the release of TSH stimulated in vitro by TRF and its inhibition by thyroxine. Neuroendocrinology 3: 34, 1968.
Crispell K.R., Parson W., Hollifield G. A study on the rate of protein synthesis before and during the administration of L-triiodothyronine to patients with myxedema and healthy volunteers using N-15 glycine. J. Clin. Invest. 35: 164, 1956.
Cotton G.E., Gorman C.A., Mayberry W.E. Suppression of thyrotropin (h-TSH) in serum of patients with myxedema of varying etiology treated with thyroid hormones. N. Engl. J. Med. 285: 529, 1971.
Vagenakis A.G., Braverman L.E., Azizi F., Portnay G.I., Ingbar S.H. Recovery of pituitary thyrotropic function after withdrawal of prolonged thyroid-suppression therapy. N. Engl. J. Med. 293: 681, 1975.
Hüfner M., Grujöendorfer M., Wahl R., Röher H.-D. Das Verhalten der thyreotropen Hypophysenfunktion bei Strumapatienten nach Absetzen einer Langzeitsup-pression mit Schilddrüsenhormonen. Klin. Wochenschr. 54: 535, 1976.
Wolff J. Transport of Iodine and other anions in the thyroid gland. Physiol. Rev. 44: 45, 1964.
Dumont J.E. The action of thyrotropin on thyroid metabolism. Vitam. Horm. 29: 287, 1971.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hoff, H.G., Hackenberg, K. & Reinwein, D. Effects of a single high oral dose of thyroxine on the pituitary-thyroid-axis. J Endocrinol Invest 4, 45–48 (1981). https://doi.org/10.1007/BF03349413
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03349413